Table 5 Dopaminergic basis of NMSS Domain 5 (attention and memory) pathophysiology in Parkinson’s disease

From: Presynaptic dopaminergic terminal imaging and non-motor symptoms assessment of Parkinson’s disease: evidence for dopaminergic basis?

Author

Year

NMS

Radiotracer

Demographics

Results

Analysis

Rinne et al.111

2000

Attention

18F-DOPA

28 PD patients and 16 healthy controls were assessed via MMSE, detailed neuropsychological assessment including tests for frontal lobe function.

Reduction of 18F-DOPA uptake in the caudate and frontal cortex is associated with a poor performance in tests requiring working memory and attention (p = 0.001).

This controlled early PET study highlights the possible dopaminergic basis of working memory and attention.

Brück et al.99

2005

Attention

18F-DOPA

21 non-medicated patients, non-demented PD patients and 24 healthy controls.

Increased tracer uptake in the medial frontal cortex and anterior cingulate correlated negatively with reaction time requiring suppressed attention (p = 0.01). Increased uptake in dorsolateral prefrontal cortex showed a positive correlation with sustained attention (p = 0.014).

This is an important controlled PET study showing a possible role of compensatory cortical mechanisms at play. The study did have a large interval between neuropsychological testing and imaging (66 days on average) which may be need to be shorter in a subsequent study.

  1. 18 F-DOPA 18F-dihydroxyphenylalanine, MMSE mini mental state examination, PD parkinson’s disease